SEC Form 4 · accession 0001179110-15-016238
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew P. Ottmer
Officer — Chief Operating Officer
Period of report
Dec 10, 2015
Accepted (ET)
Dec 14, 2015 · 4:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $16.17 | Dec 10, 2015 | A | 175,000 | A | Dec 10, 2016 | Dec 10, 2025 | Common Stock | 175,000 | 175,000 | D |
Explanation of responses
- F1Represents options granted by the issuer pursuant to the issuer's 2013 Stock Incentive Plan. Subject to certain criteria such options vest as to 25% of the shares on December 10, 2016 and as to an additional 6.25% of the shares at the end of each successive three month period following December 10, 2016.